Related Experiment Video
Updated: Jun 10, 2026

Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders
Published on: August 18, 2023
Feasibility of a self-help treatment for insomnia comorbid with cancer
Josée Savard1, Julie Villa, Sébastien Simard
1School of Psychology, Université Laval, Québec, Québec, Canada; Laval University Cancer Research Center, Québec, Québec, Canada. josee.savard@psy.ulaval.ca
Objective:
Professionally administered cognitive-behavioral therapy (CBT) is efficacious for treating insomnia in breast cancer survivors. However, given the limited accessibility to CBT for insomnia in cancer clinics, there is a need to develop other delivery formats for this intervention. This feasibility study examined patients' satisfaction with a self-help CBT for insomnia comorbid with cancer and gathered some preliminary data on its effect on sleep and associated features.
Methods:
Eleven breast cancer patients reporting insomnia symptoms received a 6-week intervention composed of a 60-min video using an animated cartoon format and 6 short booklets developed in French. Patients completed a semi-structured interview at post-treatment, a battery of self-report scales and a daily sleep diary (14 days) at pre- and post-treatment and at a 3-month follow-up.
Results:
At post-treatment interview, comments about the treatment material were uniformly positive. On a questionnaire, patients also reported to be satisfied with the treatment overall, with the video and the booklets' content, as well as with their sleep improvement at post-treatment (scores from 2.7 to 3.1; scale from 0 to 4). From pre- to post-treatment, moderate-to-large effect sizes and statistically and clinically significant differences were found on most sleep variables, as well as overall quality of life. These therapeutic gains were well sustained at a 3-month follow-up.
Conclusions:
Patients were satisfied with the treatment received. Although it is too early to draw any firm conclusion, treatment outcomes suggest a potential for integration into routine cancer care as a first-line sleep management intervention. Copyright © 2010 John Wiley & Sons, Ltd.
Related Concept Videos
Insomnia
Multiple factors contribute...
Management of Insomnia
Treatment Resistant Cancers
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Treatment Resistent Cancers